We are a start-up drug development company with a platform nanotechnology of transforming botanical (incl. mycological) extracts, or their synthetic equivalents, into unique differentiable medicinal pharmaceutical presentations. A third-party laboratory has validated our core platform, and a patent has been filed on the intellectual property in 48 countries.
The global pharmaceuticals market of botanical origin is estimated at trillion dollars and has immense growth prospects worldwide. As per the recent market trends it has been noted that 80% of the world’s population use pharmaceutical products of botanical origin in primary healthcare.
MTRX Pharmaceutical employs a novel and unique proprietary nanotechnology drug preparation and delivery platform utilizing a matrix (MTRX) of an organosulfur molecule to solvate, disperse, nano-size, stabilize, and optimize the delivery of a target medicinal molecule in solid, semisolid, and/or liquid form pharmaceutical presentations.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.